Last reviewed · How we verify

MDV3100 — Competitive Intelligence Brief

MDV3100 (mdv3100) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Androgen receptor inhibitor. Area: Oncology.

marketed Androgen receptor inhibitor Androgen receptor, Glucocorticoid receptor, Prostate-specific antigen Oncology Live · refreshed every 30 min

Target snapshot

MDV3100 (mdv3100) — Pfizer Inc..

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
MDV3100 TARGET mdv3100 Pfizer Inc. marketed Androgen receptor inhibitor Androgen receptor, Glucocorticoid receptor, Prostate-specific antigen
Talazoparib with enzalutamide talazoparib-with-enzalutamide Pfizer marketed PARP inhibitor and androgen receptor inhibitor PARP enzymes and androgen receptor Not yet launched
Winlevi CLASCOTERONE Sun Pharma marketed Androgen Receptor Inhibitor [EPC] Androgen receptor 2020-01-01
Xtandi enzalutamide Astellas Pharma marketed Androgen Receptor Inhibitor [EPC] Androgen receptor 2012-01-01
Xtandi xtandi Astellas Pharma marketed Androgen receptor inhibitor Androgen receptor 2012-01-01
Nilandron NILUTAMIDE Advanz marketed Androgen Receptor Inhibitor [EPC] Androgen receptor 1996-01-01
BICALUTAMIDE BICALUTAMIDE marketed Androgen Receptor Inhibitor [EPC] 1995-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

Sponsor landscape (Androgen receptor inhibitor class)

  1. Aragon Pharmaceuticals, Inc. · 1 drug in this class
  2. Arvinas Androgen Receptor, Inc. · 1 drug in this class
  3. Astellas Pharma · 1 drug in this class
  4. AstraZeneca · 1 drug in this class
  5. City of Hope Medical Center · 1 drug in this class
  6. Pfizer Inc. · 1 drug in this class
  7. Tata Memorial Centre · 1 drug in this class
  8. Triple Hair Inc · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). MDV3100 — Competitive Intelligence Brief. https://druglandscape.com/ci/mdv3100. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: